Cargando…

1688. Invasive Ocular Candidiasis: Who Is Really at Risk?

BACKGROUND: The Infectious Disease Society of America recommends that all patients with candidemia undergo a dilated retinal examination to exclude invasive ocular candidiasis. However, it remains unclear whether there are patients with candidemia who do not warrant routine surveillance because the...

Descripción completa

Detalles Bibliográficos
Autores principales: Seidelman, Jessica, Fleece, Molly E, Yang, Wesley Z, Bloom, Allison, Lydon, Emily, Arnold, Christopher, Weber, David J, Okeke, Nwora L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6808686/
http://dx.doi.org/10.1093/ofid/ofz360.1552
_version_ 1783461795457925120
author Seidelman, Jessica
Fleece, Molly E
Yang, Wesley Z
Bloom, Allison
Lydon, Emily
Arnold, Christopher
Weber, David J
Okeke, Nwora L
author_facet Seidelman, Jessica
Fleece, Molly E
Yang, Wesley Z
Bloom, Allison
Lydon, Emily
Arnold, Christopher
Weber, David J
Okeke, Nwora L
author_sort Seidelman, Jessica
collection PubMed
description BACKGROUND: The Infectious Disease Society of America recommends that all patients with candidemia undergo a dilated retinal examination to exclude invasive ocular candidiasis. However, it remains unclear whether there are patients with candidemia who do not warrant routine surveillance because the risk of ocular infection is low. METHODS: We conducted a retrospective cohort study of all patients with candidemia diagnosed at three academic medical centers (Duke, University of North Carolina and University of Virginia) from 2012 to 2017. We collected risk factors for invasive ocular candidiasis based on previous literature and compared them between patients with and without invasive ocular candidiasis. We then built a multivariate logistic regression model to assess which risk factors were significant for developing invasive ocular candidiasis. RESULTS: Overall, 942 patients were diagnosed with candidemia over the study period. The mean age was 55.9 years, 56% were men, 25% were non-White. Among these patients, 120 (13%) were also diagnosed with invasive ocular candidiasis, 10% with chorioretinitis and 3% with vitreous involvement. In our logistic regression analysis, central venous catheter presence [OR 8.35 (3.53, 19.77)], intravenous drug use [OR 5.02 (2.63, 9.58)], immunosuppression [OR 2.40 (1.55, 3.70)], total parenteral nutrition [OR 2.28 (1.42, 3.66)], non-White race [OR 1.65 (1.07, 2.55)], older age [OR 1.02 (1.01, 1.03)],and female gender [OR 0.57 (0.37, 0.89)] were risk factors for developing invasive ocular candidiasis. In addition, we found that persons with candidemia due to C. albicans were more likely to have invasive ocular candidiasis [OR 1.86 (1.22, 2.85)]. CONCLUSION: This cohort represents the largest study of patients with candidemia who developed invasive ocular candidiasis to date. Based on our findings, clinicians should develop targeted and cost-effective strategies for endophthalmitis screening. [Image: see text] [Image: see text] DISCLOSURES: All authors: No reported disclosures.
format Online
Article
Text
id pubmed-6808686
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-68086862019-10-28 1688. Invasive Ocular Candidiasis: Who Is Really at Risk? Seidelman, Jessica Fleece, Molly E Yang, Wesley Z Bloom, Allison Lydon, Emily Arnold, Christopher Weber, David J Okeke, Nwora L Open Forum Infect Dis Abstracts BACKGROUND: The Infectious Disease Society of America recommends that all patients with candidemia undergo a dilated retinal examination to exclude invasive ocular candidiasis. However, it remains unclear whether there are patients with candidemia who do not warrant routine surveillance because the risk of ocular infection is low. METHODS: We conducted a retrospective cohort study of all patients with candidemia diagnosed at three academic medical centers (Duke, University of North Carolina and University of Virginia) from 2012 to 2017. We collected risk factors for invasive ocular candidiasis based on previous literature and compared them between patients with and without invasive ocular candidiasis. We then built a multivariate logistic regression model to assess which risk factors were significant for developing invasive ocular candidiasis. RESULTS: Overall, 942 patients were diagnosed with candidemia over the study period. The mean age was 55.9 years, 56% were men, 25% were non-White. Among these patients, 120 (13%) were also diagnosed with invasive ocular candidiasis, 10% with chorioretinitis and 3% with vitreous involvement. In our logistic regression analysis, central venous catheter presence [OR 8.35 (3.53, 19.77)], intravenous drug use [OR 5.02 (2.63, 9.58)], immunosuppression [OR 2.40 (1.55, 3.70)], total parenteral nutrition [OR 2.28 (1.42, 3.66)], non-White race [OR 1.65 (1.07, 2.55)], older age [OR 1.02 (1.01, 1.03)],and female gender [OR 0.57 (0.37, 0.89)] were risk factors for developing invasive ocular candidiasis. In addition, we found that persons with candidemia due to C. albicans were more likely to have invasive ocular candidiasis [OR 1.86 (1.22, 2.85)]. CONCLUSION: This cohort represents the largest study of patients with candidemia who developed invasive ocular candidiasis to date. Based on our findings, clinicians should develop targeted and cost-effective strategies for endophthalmitis screening. [Image: see text] [Image: see text] DISCLOSURES: All authors: No reported disclosures. Oxford University Press 2019-10-23 /pmc/articles/PMC6808686/ http://dx.doi.org/10.1093/ofid/ofz360.1552 Text en © The Author(s) 2019. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Abstracts
Seidelman, Jessica
Fleece, Molly E
Yang, Wesley Z
Bloom, Allison
Lydon, Emily
Arnold, Christopher
Weber, David J
Okeke, Nwora L
1688. Invasive Ocular Candidiasis: Who Is Really at Risk?
title 1688. Invasive Ocular Candidiasis: Who Is Really at Risk?
title_full 1688. Invasive Ocular Candidiasis: Who Is Really at Risk?
title_fullStr 1688. Invasive Ocular Candidiasis: Who Is Really at Risk?
title_full_unstemmed 1688. Invasive Ocular Candidiasis: Who Is Really at Risk?
title_short 1688. Invasive Ocular Candidiasis: Who Is Really at Risk?
title_sort 1688. invasive ocular candidiasis: who is really at risk?
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6808686/
http://dx.doi.org/10.1093/ofid/ofz360.1552
work_keys_str_mv AT seidelmanjessica 1688invasiveocularcandidiasiswhoisreallyatrisk
AT fleecemollye 1688invasiveocularcandidiasiswhoisreallyatrisk
AT yangwesleyz 1688invasiveocularcandidiasiswhoisreallyatrisk
AT bloomallison 1688invasiveocularcandidiasiswhoisreallyatrisk
AT lydonemily 1688invasiveocularcandidiasiswhoisreallyatrisk
AT arnoldchristopher 1688invasiveocularcandidiasiswhoisreallyatrisk
AT weberdavidj 1688invasiveocularcandidiasiswhoisreallyatrisk
AT okekenworal 1688invasiveocularcandidiasiswhoisreallyatrisk